Hvilken er prisen på Probi AB (publ) (PROB)

Prisen på Probi AB (publ) (PROB) er $38.87

Hva er markedsverdien på Probi AB (publ) (PROB)

Markedsverdien på Probi AB (publ) (PROB) er $442.88M

Probi AB (publ) (PROB) Aksjesplitter

Probi AB (publ) specializes in the research, development, manufacturing, marketing, and distribution of probiotics for the health, pharmaceutical, and food sectors. The company's scientific endeavors primarily focus on areas such as gastrointestinal, digestive, immune, and bone health, as well as iron absorption, and the specific health requirements of children, women, and seniors. Their product range includes dietary supplements and various food and beverage applications, offered in diverse formats like capsules, tablets (including chewable), spheres, powders, and an array of drinks such as fruit drinks, shots, carbonated beverages, and recovery drinks. Probi's products are sold in approximately 40 countries globally. The company also fosters collaborations, including a partnership with Örebro University for exploring needle-free vaccines and with La Trobe University for a clinical trial assessing the effects of Probi Osteo in Australian women. Established in 1991 and headquartered in Lund, Sweden, Probi AB (publ) operates as a subsidiary of Symrise AG.

År	Splitt	Multiplikator	Kumulativ multiplikator
Ikke nok data for de angitte datoene.

År

Splitt

Multiplikator

Kumulativ multiplikator

Ikke nok data for de angitte datoene.

Selskap	Antall aksjesplitt	Kumulativ multiplikator	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN
Galderma Group AG GALD.SW	0	-	CH

Selskap

Antall aksjesplitt

Kumulativ multiplikator

Land